Welcome to LookChem.com Sign In|Join Free
  • or
1,3,2-Dioxaborolane, 2-(5-chloro-2-methoxyphenyl)-4,4,5,5-tetramethyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

635305-45-2

Post Buying Request

635305-45-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

635305-45-2 Usage

Type of Compound

Boronic acid derivative

Structure

Tetramethyl substitution on the boron atom and a chloro-methoxyphenyl substitution on the carbon atom

Applications

a. Organic synthesis
b. Medicinal chemistry

Role in Suzuki-Miyaura Cross-Coupling Reactions

Used as a reagent for creating carbon-carbon bonds in organic molecules

Therapeutic Potential

Studied for its potential in treating various diseases, including cancer and other inflammatory conditions

Check Digit Verification of cas no

The CAS Registry Mumber 635305-45-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,3,0 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 635305-45:
(8*6)+(7*3)+(6*5)+(5*3)+(4*0)+(3*5)+(2*4)+(1*5)=142
142 % 10 = 2
So 635305-45-2 is a valid CAS Registry Number.

635305-45-2Relevant academic research and scientific papers

Nickel-Catalyzed Coupling Reaction of α-Bromo-α-fluoroketones with Arylboronic Acids toward the Synthesis of α-Fluoroketones

Liang, Junqing,Han, Jie,Wu, Jingjing,Wu, Pingjie,Hu, Jian,Hu, Feng,Wu, Fanhong

supporting information, p. 6844 - 6849 (2019/09/07)

A nickel-catalyzed coupling reaction of α-bromo-α-fluoroketones with arylboronic acids was reported, which provides an efficient pathway to access 2-fluoro-1,2-diarylethanones in high yields. We also disclosed the synthesis of the monofluorination agents

Novel synthesis method for Flindokalner raceme

-

Paragraph 0015, (2019/10/01)

The invention discloses a novel synthesis method for a Flindokalner raceme. The method comprises the steps: subjecting 3-fluoro-3-(2,2,2-trifluoro-1,1-dihydroxyethyl)-6(trifluoromethyl)2H-indol-2-one, which serves as a raw material, to a bromation reactio

Ortho-Selective C-H Borylation of Aromatic Ethers with Pinacol-borane by Organo Rare-Earth Catalysts

Xue, Can,Luo, Yong,Teng, Huailong,Ma, Yuanhong,Nishiura, Masayoshi,Hou, Zhaomin

, p. 5017 - 5022 (2018/05/14)

The regioselective C-H borylation of aromatic ethers such as anisoles is of much interest and importance, but has remained a challenge to date. We report herein the catalytic ortho-selective C-H borylation of a wide range of aromatic ethers with pinacolborane (HBpin) by rare-earth metallocene complexes. This protocol offers an efficient and straightforward route for the synthesis of a variety of borylated aromatic ether derivatives. A proper metal/ligand combination for the rare-earth metal catalysts was found to be critically important to promote this transformation.

Rhodium-catalyzed intermolecular C-H silylation of arenes with high steric regiocontrol

Chen, Cheng,Hartwig, John F.

, p. 853 - 857 (2014/03/21)

Regioselective C-H functionalization of arenes has widespread applications in synthetic chemistry. The regioselectivity of these reactions is often controlled by directing groups or steric hindrance ortho to a potential reaction site. Here, we report a catalytic intermolecular C-H silylation of unactivated arenes that manifests very high regioselectivity through steric effects of substituents meta to a potential site of reactivity. The silyl moiety can be further functionalized under mild conditions but is also inert toward many common organic transformations, rendering the silylarene products useful building blocks. The remote steric effect that we observe results from the steric properties of both the rhodium catalyst and the silane.

PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF

-

Page 34, (2008/06/13)

Use of compounds to inhibit hormone-sensitive lipase, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds, method of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitve lipase and may be useful in the treatment and/or prevention of a range of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 635305-45-2